Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| TELA Bio to Present at the Jefferies Virtual Healthcare Conference | ||
| By: GlobeNewswire - 29 May 2020 | Back to overview list |
|
MALVERN, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced the company will be participating in the upcoming Jefferies Virtual Healthcare Conference. TELA Bio's management is scheduled to present on Tuesday, June 2, 2020 at 9:00 AM Eastern Daylight Time (EDT). Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at ir.telabio.com. About TELA Bio, Inc. TELA Bio, Inc. is a commercial stage medical technology company focused on designing, developing, and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. TELA's products are designed to improve on shortcomings of existing biologics and minimize long-term exposure to permanent synthetic material. TELA's portfolio is supported by quality, data-driven science and extensive pre-clinical research that has consistently demonstrated advantages over other commercially available products. TELA Bio Contact Investor Contact |
||
|
||
 | Back to overview list | |